Nouveautés dans la stéatose non alcoolique du foie (NAFLD) [New trends in non-alcoholic fatty liver diseases (NAFLD)]
Fiche du document
25 mars 2020
- doi: 10.53738/REVMED.2020.16.687.0586
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.687.0586
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32216182
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8016303EAF6D5
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Diseases and hygiene Sickness Human beings--Diseases Morbidity Illness Sicknesses Illnesses illnessCiter ce document
M. Barigou et al., « Nouveautés dans la stéatose non alcoolique du foie (NAFLD) [New trends in non-alcoholic fatty liver diseases (NAFLD)] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.687.0586
Métriques
Partage / Export
Résumé
Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases with an epidemiology correlated to obesity and metabolic syndrome. The last decade was rich of significant advances in understanding the pathophysiology of the disease, linking environmental elements, genetic factors and microbiota modifications, as well as in staging, screening and therapeutic development. The purpose of this article is to summarize recent advances in the field of NAFLD, on her way to become the first cause of cirrhosis and liver transplantation worldwide.